Management of Terminal Illness: A Medical School-Hospice Partnership Model to Teach Medical Students About End-of-Life Care

Abstract

Physicians are not only called upon to deal with biological, but also with psychosocial issues and concerns in the treatment of the terminally ill. Their training, however, usually does not prepare them to value palliative care, or help them cope with personal feelings about death and possible grief over a patient's loss. The authors describe what one medical school is doing regarding the challenge of preparing medical students to deal more competently and confidently with end-of-life scenarios they will encounter as primary care practitioners in underserved areas of a rural state.

Palliative Care and Death Anxiety

“…Olumsuz tutumların değiştirilebilmesi için, temel hedefi duygusal gelişimi desteklemek olan ölüm eğitimi ve farkındalık programlarına gereksinim vardır. [12,13,21,22]…”

Palliative Care in Undergraduate Medical Education—How Far Have We Come?

“…Thematic analysis of remaining articles is summarized in Table 1, including articles discussing hospice placements, 3,54,94 –107 technology or online learning, 108,109 simulation, 110 –113 and interprofessional learning opportunities. 111 A range of novel teaching methods were also discussed within the literature.…”

The Influence of the End of Life on the Extent of Informal Help Received by Older Adults

“…Of the 607 matches for the first two, most involved formal care professionals and facilities concerning the treatment or transfer of dying patients with chronic diseases rather than in-home care of older adults. For example, a sample of the 100 most recent studies showed 21 articles on physician/nurse/medical student training for treating patients at the end of life (e.g., Cowell et al 2002). There were 22 articles dealing with treatment in formal care settings (e.g., Froggatt, Poole, and Hoult 2002;Jacobs, Bonuck, and Burton 2002;Pantilat 2002) and another 14 articles on the experiences or treatment of patients with specific diseases at the end of life (e.g., Bruera 2002;Ganzini, Johnston, and Silveira 2002).…”